We hypothesized that ASM cells from people with COPD may constitutively produce higher levels of FBLN-1 than ASM cells from people without COPD, and TGF-β1 stimulation would further increase the production of FBLN-1. This evidence concerns the gene FBLN1 and chronic obstructive pulmonary disease.